SBC
SBC Medical Group Holdings Incorporated
NASDAQ: SBC · INDUSTRIALS · CONSULTING SERVICES
$5.04
+0.40% today
Updated 2026-11-06
Market cap
$518.35M
P/E ratio
10.72
P/S ratio
2.96x
EPS (TTM)
$0.47
Dividend yield
—
52W range
$3 – $6
Volume
0.2M
WallStSmart proprietary scores
72
out of 100
Grade: B
Buy
Investment rating
6.0
Growth
B8.5
Quality
A9.0
Profitability
A+6.3
Valuation
B2/9
Piotroski F-Score
Weak
3.9
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →248 stocks currently score above 75
Price targets
Analyst target
$8.75
+73.61%
12-Month target
$4.95
-1.79%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 3.94 — safe zone
+ Profit margin 28.00% — above average
+ Free cash flow $22.04M — positive
+ Revenue growth 13.40% QoQ
+ Debt/equity 0.18x — low leverage
Risks
- Piotroski 2/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $174.16M | $193.54M | $205.42M | $173.61M | $175.17M |
| Net income | $6.32M | $39.37M | $46.61M | $50.99M | $10.69M |
| EPS | — | — | — | — | $0.47 |
| Free cash flow | $-24.99M | $39.44M | $17.17M | $36.55M | $22.04M |
| Profit margin | 3.63% | 20.34% | 22.69% | 29.37% | 28.00% |
Peer comparison
Smart narrative
SBC Medical Group Holdings Incorporated trades at $5.04. representing a P/E of 10.72x trailing earnings. Our Smart Value Score of 72/100 indicates the stock is good. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 3.94, it sits in the safe zone. TTM revenue stands at $175.17M. with profit margins at 28.00%.
Frequently asked questions
What is SBC Medical Group Holdings Incorporated's stock price?
SBC Medical Group Holdings Incorporated (SBC) trades at $5.04, on a P/E of 10.7x and a P/S of 3.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is SBC Medical Group Holdings Incorporated overvalued?
SBC Medical Group Holdings Incorporated carries a Smart Value Score of 72/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read.
What is the price target of SBC Medical Group Holdings Incorporated (SBC)?
The 12-month analyst consensus target is $8.75, about 73.6% above the current $5.04. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is SBC Medical Group Holdings Incorporated's revenue?
SBC Medical Group Holdings Incorporated's trailing twelve-month revenue is $175.17M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
SBC Medical Group Holdings Incorporated's Altman Z-Score is 3.94, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorINDUSTRIALS
IndustryCONSULTING SERVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.96x
ROE18.58%
Beta0.52
50D MA$4.97
200D MA$3.93
Shares out0.10B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week-4.83%
1 month-5.99%
3 months+64.05%
YTD+16.47%
1 year+59.37%
3 years—
5 years—